Cancer BiologybioRxivPreprint
Dynamics of circulating tumor cell subsets defined by PSMA and EpCAM predict survival in metastatic castration-resistant prostate cancer patients treated with 177Lu-PSMA-617
Madeline J. Lee, Lauren Yu, Nicholas A. Zorko…·Ali T. Arafa
The paper assesses CTC subset dynamics in mCRPC patients treated with 177Lu-PSMA-617 and finds that changes in PSMA and EpCAM-expressing CTCs correlate with survival outcomes.
DOI 10.64898/2026.09.14.751487